Skip to main content
Erschienen in: European Journal of Nutrition 3/2022

10.01.2022 | Original Contribution

Association of soy food with cardiovascular outcomes and all-cause mortality in a Chinese population: a nationwide prospective cohort study

verfasst von: Ting Xue, Junping Wen, Qin Wan, Guijun Qin, Li Yan, Guixia Wang, Yingfen Qin, Zuojie Luo, Xulei Tang, Yanan Huo, Ruying Hu, Zhen Ye, Lixin Shi, Zhengnan Gao, Qing Su, Yiming Mu, Jiajun Zhao, Lulu Chen, Tianshu Zeng, Xuefeng Yu, Qiang Li, Feixia Shen, Li Chen, Yinfei Zhang, Youmin Wang, Huacong Deng, Chao Liu, Shengli Wu, Tao Yang, Mian Li, Yu Xu, Min Xu, Tiange Wang, Zhiyun Zhao, Jieli Lu, Yufang Bi, Weiqing Wang, Gang Chen, Guang Ning

Erschienen in: European Journal of Nutrition | Ausgabe 3/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This study aimed to clarify the association of soy intake with cardiovascular disease (CVD) and all-cause mortality.

Methods

We conducted a prospective cohort study in a Chinese population composed of 97,930 participants aged ≥ 40 years old without CVD at baseline in 2011. Habitual soy intake over a period of 12 months was evaluated using a food frequency questionnaire. All participants were classified into four groups based on their soy food consumption levels: < 15, 15–29, 30–59, and ≥ 60 g/day, with the lowest category as the reference group. Follow-up was conducted between 2014 and 2016 to assess CVD incidence and all-cause mortality since baseline, which was collected from the local mortality and disease registers of the National Disease Surveillance Point System and National Health Insurance System. The Cox proportional hazards regression models were used to analyze the relationship of soy intake with later CVD events and all-cause mortality.

Results

During 350,604 person-years of follow-up (median [interquartile range]: 3.16 [2.98, 4.77] years), 2523 total CVD events and 1473 all-cause mortalities were documented. After controlling for covariates, the hazard ratios (95% confidence intervals) for total CVD events across increasing soy intake levels were 1.03 (0.93–1.14); 0.96 (0.86–1.07); and 0.86 (0.75–0.98; p for trend = 0.0434), while those for all-cause mortality were 0.88 (0.77–1.02); 0.86 (0.74–1.00); and 0.83 (0.69–0.99; p for trend = 0.0084).

Conclusion

High soy intake was associated with a reduced risk of total CVD events and all-cause mortality among a Chinese population.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
3.
Zurück zum Zitat Li N, Wu X, Zhuang W, Xia L, Chen Y, Zhao R, Yi M, Wan Q, Du L, Zhou Y (2020) Soy and isoflavone consumption and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomized trials in humans. Mol Nutr Food Res 64:e1900751. https://doi.org/10.1002/mnfr.201900751CrossRefPubMed Li N, Wu X, Zhuang W, Xia L, Chen Y, Zhao R, Yi M, Wan Q, Du L, Zhou Y (2020) Soy and isoflavone consumption and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomized trials in humans. Mol Nutr Food Res 64:e1900751. https://​doi.​org/​10.​1002/​mnfr.​201900751CrossRefPubMed
5.
Zurück zum Zitat Hay SI, Abajobir AA, Abate KH et al (2017) Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 390:1260–1344. https://doi.org/10.1016/s0140-6736(17)32130-xCrossRef Hay SI, Abajobir AA, Abate KH et al (2017) Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 390:1260–1344. https://​doi.​org/​10.​1016/​s0140-6736(17)32130-xCrossRef
20.
Zurück zum Zitat Li M, Xu Y, Wan Q et al (2020) Individual and combined associations of modifiable lifestyle and metabolic health status with new-onset diabetes and major cardiovascular events: the China Cardiometabolic Disease and Cancer Cohort (4C) study. Diabetes Care 43:1929–1936. https://doi.org/10.2337/dc20-0256CrossRefPubMed Li M, Xu Y, Wan Q et al (2020) Individual and combined associations of modifiable lifestyle and metabolic health status with new-onset diabetes and major cardiovascular events: the China Cardiometabolic Disease and Cancer Cohort (4C) study. Diabetes Care 43:1929–1936. https://​doi.​org/​10.​2337/​dc20-0256CrossRefPubMed
23.
Zurück zum Zitat Yang Y (2005) China food composition 2004 book 2, Chinese. Peking University Medical Press, Beijing Yang Y (2005) China food composition 2004 book 2, Chinese. Peking University Medical Press, Beijing
24.
Zurück zum Zitat Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, Jones DW, Kurtz T, Sheps SG, Roccella EJ (2005) Recommendations for blood pressure measurement in humans and experimental animals. Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on high blood pressure research. Circulation 111:697–716. https://doi.org/10.1161/01.Cir.0000154900.76284.F6CrossRefPubMed Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, Jones DW, Kurtz T, Sheps SG, Roccella EJ (2005) Recommendations for blood pressure measurement in humans and experimental animals. Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on high blood pressure research. Circulation 111:697–716. https://​doi.​org/​10.​1161/​01.​Cir.​0000154900.​76284.​F6CrossRefPubMed
Metadaten
Titel
Association of soy food with cardiovascular outcomes and all-cause mortality in a Chinese population: a nationwide prospective cohort study
verfasst von
Ting Xue
Junping Wen
Qin Wan
Guijun Qin
Li Yan
Guixia Wang
Yingfen Qin
Zuojie Luo
Xulei Tang
Yanan Huo
Ruying Hu
Zhen Ye
Lixin Shi
Zhengnan Gao
Qing Su
Yiming Mu
Jiajun Zhao
Lulu Chen
Tianshu Zeng
Xuefeng Yu
Qiang Li
Feixia Shen
Li Chen
Yinfei Zhang
Youmin Wang
Huacong Deng
Chao Liu
Shengli Wu
Tao Yang
Mian Li
Yu Xu
Min Xu
Tiange Wang
Zhiyun Zhao
Jieli Lu
Yufang Bi
Weiqing Wang
Gang Chen
Guang Ning
Publikationsdatum
10.01.2022
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nutrition / Ausgabe 3/2022
Print ISSN: 1436-6207
Elektronische ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-021-02724-8

Weitere Artikel der Ausgabe 3/2022

European Journal of Nutrition 3/2022 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Ist Fasten vor Koronarinterventionen wirklich nötig?

Wenn Eingriffe wie eine Koronarangiografie oder eine Koronarangioplastie anstehen, wird häufig empfohlen, in den Stunden zuvor nüchtern zu bleiben. Ein französisches Forscherteam hat diese Maßnahme hinterfragt.

Typ-2-Diabetes: Ernährungsunsicherheit vervierfacht Risiko für schwere Hypoglykämien

04.06.2024 Typ-2-Diabetes Nachrichten

Wenn ältere Menschen mit Typ-2-Diabetes Schwierigkeiten beim Beschaffen und Zubereiten von Mahlzeiten haben, geht dies mit einem deutlich gesteigerten Risiko für schwere Hypoglykämien einher.

Mehr Brustkrebs, aber weniger andere gynäkologische Tumoren mit Levonorgestrel-IUS

04.06.2024 Levonorgestrel Nachrichten

Unter Frauen, die ein Levonorgestrel-freisetzendes intrauterines System (IUS) verwenden, ist die Brustkrebsrate um 13% erhöht. Dafür kommt es deutlich seltener zu Endometrium-, Zervix- und Ovarialkarzinomen.

GLP-1-Agonist Semaglutid wirkt kardio- und nephroprotektiv

03.06.2024 Semaglutid Nachrichten

Der GLP-1-Agonist Semaglutid hat in der FLOW-Studie bewiesen, dass sich damit die Progression chronischer Nierenerkrankungen bei Patienten mit Typ-2-Diabetes bremsen lässt. Auch in kardiovaskulärer Hinsicht war die Therapie erfolgreich.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.